Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2014 3
2015 4
2016 4
2017 6
2019 1
2020 1
2021 1
2022 7
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
A Phase 1 Trial of Salvage Stereotactic Body Radiation Therapy for Radiorecurrent Prostate Cancer After Brachytherapy.
Patel KR, Rydzewski NR, Schott E, Cooley-Zgela T, Ning H, Cheng J, Salerno K, Huang EP, Lindenberg L, Mena E, Choyke P, Turkbey B, Citrin DE. Patel KR, et al. Among authors: huang ep. Int J Radiat Oncol Biol Phys. 2024 Feb 29:S0360-3016(24)00323-7. doi: 10.1016/j.ijrobp.2024.02.014. Online ahead of print. Int J Radiat Oncol Biol Phys. 2024. PMID: 38428681 Free article.
A Phase 1 Trial of Focal Salvage Stereotactic Body Radiation Therapy for Radiorecurrent Prostate Cancer.
Patel KR, Rydzewski NR, Schott E, Cooley-Zgela T, Ning H, Cheng J, Salerno K, Huang EP, Pinto PA, Lindenberg L, Mena E, Choyke P, Turkbey B, Citrin DE. Patel KR, et al. Among authors: huang ep. Pract Radiat Oncol. 2023 Nov-Dec;13(6):540-550. doi: 10.1016/j.prro.2023.05.012. Epub 2023 Jul 11. Pract Radiat Oncol. 2023. PMID: 37442430 Free article. Clinical Trial.
Criteria for the translation of radiomics into clinically useful tests.
Huang EP, O'Connor JPB, McShane LM, Giger ML, Lambin P, Kinahan PE, Siegel EL, Shankar LK. Huang EP, et al. Nat Rev Clin Oncol. 2023 Feb;20(2):69-82. doi: 10.1038/s41571-022-00707-0. Epub 2022 Nov 28. Nat Rev Clin Oncol. 2023. PMID: 36443594 Free PMC article. Review.
Multiparametric Quantitative Imaging in Risk Prediction: Recommendations for Data Acquisition, Technical Performance Assessment, and Model Development and Validation.
Huang EP, Pennello G, deSouza NM, Wang X, Buckler AJ, Kinahan PE, Barnhart HX, Delfino JG, Hall TJ, Raunig DL, Guimaraes AR, Obuchowski NA. Huang EP, et al. Acad Radiol. 2023 Feb;30(2):196-214. doi: 10.1016/j.acra.2022.09.018. Epub 2022 Oct 21. Acad Radiol. 2023. PMID: 36273996 Free PMC article. Review.
Trends in Grade 5 Toxicity and Response in Phase I Trials in Hematologic Malignancy: 20-Year Experience From the Cancer Therapy Evaluation Program at the National Cancer Institute.
Chihara D, Huang EP, Finnigan SR, Cordes LM, Skorupan N, Fukuda Y, Rubinstein LV, Ivy SP, Doroshow JH, Nastoupil LJ, Flowers CR, Takebe N. Chihara D, et al. Among authors: huang ep. J Clin Oncol. 2022 Jun 10;40(17):1949-1957. doi: 10.1200/JCO.21.02190. Epub 2022 Mar 9. J Clin Oncol. 2022. PMID: 35263120 Free PMC article. Clinical Trial.
26 results